Richard Prins - Amphastar Independent Director

AMPH Stock  USD 42.02  0.91  2.21%   

Director

Mr. Richard K. Prins is Independent Director of the Company. Since 2008, Mr. Prins has served as a member of our board of directors since February 2002. Since 2008, Mr. Prins was a private investor and involved in various charitable organizations. Mr. Prins also volunteers as acting head of U.S. Operations for Advancing Native Missions and serves on the board of directors of India Globalization Capital, Inc. Mr. Prins was the Director of Investment Banking for FBW, from 1996 until June 2008 when FBW was acquired by Royal Bank of Canada and served as a consultant to Royal Bank of Canada Capital Markets through December 2008. Prior to FBW, Mr. Prins was a Managing Director from July 1988 to April 1996 at Crestar Bank in charge of mergers and acquisitions. Mr. Prins began his career in 1983 as the Assistant to the Chairman of the leverage buyout company, Tuscarora Corporationration, where he held various positions until July 1988 since 2002.
Age 61
Tenure 22 years
Professional MarksMBA
Address 11570 6th Street, Rancho Cucamonga, CA, United States, 91730
Phone909 980 9484
Webhttps://www.amphastar.com
Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.

Amphastar Management Efficiency

The company has return on total asset (ROA) of 0.1107 % which means that it generated a profit of $0.1107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2355 %, meaning that it created $0.2355 on every $100 dollars invested by stockholders. Amphastar's management efficiency ratios could be used to measure how well Amphastar manages its routine affairs as well as how well it operates its assets and liabilities. The Amphastar's current Return On Tangible Assets is estimated to increase to 0.16. The Amphastar's current Return On Capital Employed is estimated to increase to 0.16. As of now, Amphastar's Intangible Assets are increasing as compared to previous years. The Amphastar's current Return On Tangible Assets is estimated to increase to 0.16, while Other Assets are projected to decrease to under 35.9 M.
The company currently holds 623.64 M in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Amphastar P has a current ratio of 3.57, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Amphastar until it has trouble settling it off, either with new capital or with free cash flow. So, Amphastar's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amphastar P sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amphastar to invest in growth at high rates of return. When we think about Amphastar's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Greg GarlandAmgen Inc
56
Pamela CraigWalmart
60
Marshall LarsenAir Lease
72
Shumeet BanerjiHP Inc
61
Stephanie BurnsHP Inc
66
Robert WilliamsAmgen Inc
69
Jim UmplebyChevron Corp
59
Cheryl KrongardAir Lease
65
John StumpfChevron Corp
61
Jon HuntsmanChevron Corp
60
Charles MoormanChevron Corp
68
Debra ReedKlagesChevron Corp
63
Wanda AustinAmgen Inc
63
Timothy FlynnWalmart
64
John FrankChevron Corp
64
Thomas HortonWalmart
59
Inge ThulinChevron Corp
64
Robert MiltonAir Lease
60
Alice GastChevron Corp
61
Carla HarrisWalmart
58
Jim WaltonWalmart
65
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people. Amphastar P (AMPH) is traded on NASDAQ Exchange in USA. It is located in 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 and employs 1,761 people. Amphastar is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Amphastar P Leadership Team

Elected by the shareholders, the Amphastar's board of directors comprises two types of representatives: Amphastar inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amphastar. The board's role is to monitor Amphastar's management team and ensure that shareholders' interests are well served. Amphastar's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amphastar's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Shohet, Independent Director
Ziping Luo, Chief Chairman
Peter Langosh, VP Audit
Richard Koo, Independent Director
Marilyn Purchase, Corporate Executive VP of Operations and President of International Medication Systems Ltd
Michael Zasloff, Independent Director
Jason Shandell, President Director
Jacob MBA, Marketing Sales
William Peters, CFO, Sr. VP and Treasurer
Floyd Petersen, Independent Director
Jacob Liawatidewi, Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary
Rong Zhou, Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc.
MP MBA, Senior Operations
Richard Prins, Independent Director
William MBA, Executive CFO
Rong MS, Senior Production
Dan MBA, Vice Communication
Mary Luo, Chairman, Chief Scientist and COO
Howard Lee, Independent Director
Yongfeng Zhang, President, CoFounder
Jack Zhang, CEO, Chief Science Officer and Director
Diane Gerst, President Amphastar Nanjing Pharmaceuticals Co., Ltd

Amphastar Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amphastar a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Amphastar Investors Sentiment

The influence of Amphastar's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amphastar. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amphastar's public news can be used to forecast risks associated with an investment in Amphastar. The trend in average sentiment can be used to explain how an investor holding Amphastar can time the market purely based on public headlines and social activities around Amphastar P. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amphastar's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amphastar's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amphastar's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amphastar.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amphastar in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amphastar's short interest history, or implied volatility extrapolated from Amphastar options trading.

Pair Trading with Amphastar

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amphastar position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amphastar will appreciate offsetting losses from the drop in the long position's value.

Moving against Amphastar Stock

  0.92GE GE Aerospace Earnings Call This WeekPairCorr
  0.89CAT Caterpillar Financial Report 6th of August 2024 PairCorr
  0.88MMM 3M Company Financial Report 23rd of July 2024 PairCorr
  0.87BAC Bank of America Financial Report 16th of July 2024 PairCorr
  0.79WMT Walmart Financial Report 16th of May 2024 PairCorr
The ability to find closely correlated positions to Amphastar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amphastar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amphastar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amphastar P to buy it.
The correlation of Amphastar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amphastar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amphastar P moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amphastar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Amphastar Stock analysis

When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Amphastar's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.055
Earnings Share
2.6
Revenue Per Share
13.351
Quarterly Revenue Growth
0.319
Return On Assets
0.1107
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.